Nestibil (Bilastine)

Bilastine selectively blocks peripheral H1 histamine receptors. By preventing histamine from binding to these receptors on mast cells, blood vessels and sensory nerves, it stops the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation, thereby reducing allergy‑related symptoms.

The dosage of Nestibil is determined by the prescribing healthcare professional based on the patient’s age, weight, renal and hepatic function, and the specific indication. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for bilastine in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against possible risks before prescribing Nestibil to pregnant or nursing women, and it should only be used if clearly needed.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with first‑generation antihistamines, bilastine offers a non‑sedating profile and selective H1 antagonism, reducing the risk of drowsiness. Relative to other second‑generation agents, its efficacy in allergic rhinitis and urticaria is comparable, while its drug‑interaction profile is modest, especially concerning P‑gp inhibitors.

Nestibil should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture, heat and direct sunlight to maintain potency throughout the shelf life.

Nestibil is taken orally, usually with a glass of water. It can be taken with or without food, but patients should avoid simultaneous intake of antacids containing aluminum or magnesium as they may reduce absorption.

While rare, serious adverse reactions can include anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience signs of a severe allergic reaction, rash, or irregular heartbeat.

Nestibil is contraindicated in individuals with known hypersensitivity to bilastine or any of its excipients. Caution is advised for patients with severe renal or hepatic impairment, and it should be avoided in those taking strong P‑gp inhibitors unless supervised by a clinician.